US Stock MarketDetailed Quotes
ATHE Alterity Therapeutics
- 2.5100
- +0.2500+11.06%
Close Apr 26 16:00 ET
- 2.5000
- -0.0100-0.40%
Post 19:50 ET
21.91MMarket Cap-1283P/E (TTM)
2.7499High2.2600Low87.87KVolume2.2600Open2.2600Pre Close216.86KTurnover1.11%Turnover RatioLossP/E (Static)8.73MShares5.410052wk High1.91P/B19.87MFloat Cap1.550052wk Low--Dividend TTM7.92MShs Float51.5000Historical High--Div YieldTTM21.68%Amplitude1.5500Historical Low2.4670Avg Price1Lot Size
Alterity Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | (FY)Jun 30, 2017 | (FY)Jun 30, 2016 | (FY)Jun 30, 2015 | (FY)Jun 30, 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | -7.19%132.4K | -19.33%142.66K | -51.39%176.84K | 141.12%363.78K |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | -7.19%132.4K | -19.33%142.66K | -51.39%176.84K | 141.12%363.78K |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -5.18%14.35M | 2.70%15.14M | 9.45%14.74M | 7.96%13.47M | 58.96%12.47M | 15.87%7.85M | -20.21%6.77M | -19.37%8.49M | -15.38%10.53M | 62.81%12.44M |
| Selling and administrative expenses | -9.57%4.94M | -20.44%5.46M | 105.85%6.86M | -22.09%3.33M | 2.00%4.28M | 6.27%4.19M | 10.02%3.95M | -19.82%3.59M | -8.74%4.47M | 35.12%4.9M |
| -General and administrative expense | -9.57%4.94M | -20.44%5.46M | 105.85%6.86M | -22.09%3.33M | 2.00%4.28M | 6.27%4.19M | 10.02%3.95M | -19.82%3.59M | -8.74%4.47M | 40.39%4.9M |
| Research and development costs | -10.49%13.2M | 20.04%14.75M | 21.64%12.28M | -22.22%10.1M | 93.84%12.98M | 17.50%6.7M | -40.53%5.7M | -22.06%9.59M | -17.51%12.3M | 81.72%14.91M |
| Depreciation amortization depletion | 88.63%102.26K | -28.07%54.21K | -32.96%75.37K | 278.59%112.43K | 36.23%29.7K | 2.21%21.8K | -6.50%21.33K | -27.79%22.81K | 41.11%31.59K | -3.23%22.38K |
| -Depreciation and amortization | 88.63%102.26K | -28.07%54.21K | -32.96%75.37K | 278.59%112.43K | 36.23%29.7K | 2.21%21.8K | -6.50%21.33K | -27.79%22.81K | 41.11%31.59K | -3.23%22.38K |
| Other taxes | 16.17%-3.91M | -13.16%-4.67M | ---4.13M | --0 | -58.40%-4.95M | -3.41%-3.13M | 36.41%-3.02M | 21.93%-4.75M | 21.97%-6.09M | -76.99%-7.8M |
| Other operating expenses | 106.49%29.4K | -27.01%-452.96K | -354.24%-356.63K | -159.05%-78.51K | 128.57%132.97K | -53.86%58.17K | 178.45%126.07K | 123.91%45.28K | -146.31%-189.33K | 111.38%408.8K |
| Operating profit | 5.18%-14.35M | -2.70%-15.14M | -9.45%-14.74M | -7.96%-13.47M | -58.96%-12.47M | -18.18%-7.85M | 20.43%-6.64M | 19.37%-8.34M | 14.30%-10.35M | -61.24%-12.08M |
| Net non-operating interest income expense | 556.39%16.44K | -87.89%2.5K | 20.79%20.68K | -84.23%17.12K | -46.05%108.54K | 201.17K | -69.60%-29.98K | |||
| Non-operating interest income | 556.39%16.44K | -87.89%2.5K | 20.79%20.68K | -84.23%17.12K | -46.05%108.54K | --201.17K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 69.60%29.98K |
| Other net income (expense) | -72.35%651.84K | 498.72%2.36M | -7,432.00%-591.34K | -129.11%-7.85K | 105.44%26.97K | 45.08%-495.44K | -246.61%-902.11K | -86.22%615.29K | 464.82%4.46M | -336.73%-1.22M |
| Gain on sale of security | -65.66%934.8K | 1,276.96%2.72M | -167.03%-231.31K | -1.14%345.07K | 228.87%349.06K | 58.97%-270.86K | -177.02%-660.21K | -81.84%857.25K | 732.40%4.72M | -630.40%-746.59K |
| Other non- operating income (expenses) | 22.40%-282.96K | -1.29%-364.67K | -2.01%-360.03K | -9.57%-352.92K | -43.42%-322.1K | 7.16%-224.58K | 0.03%-241.89K | 5.96%-241.95K | 46.07%-257.3K | -13.33%-477.08K |
| Income before tax | -7.24%-13.7M | 16.54%-12.78M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M | -71.17%-13.33M |
| Income tax | 49.21%104.46K | 70.01K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M | -71.17%-13.33M |
| Net income continuous Operations | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M | -71.17%-13.33M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M | -71.17%-13.33M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -7.47%-13.81M | 16.08%-12.85M | -13.77%-15.31M | -9.07%-13.46M | -49.26%-12.34M | -9.59%-8.27M | 2.43%-7.54M | -31.34%-7.73M | 55.85%-5.89M | -71.17%-13.33M |
| Basic earnings per share | -7.55%-3.42 | 41.11%-3.18 | 40.00%-5.4 | 25.00%-9 | -29.03%-12 | -9.93%-9.3 | 2.76%-8.46 | -23.93%-8.7 | 62.38%-7.02 | -35.22%-18.66 |
| Diluted earnings per share | -7.55%-3.42 | 41.11%-3.18 | 40.00%-5.4 | 25.00%-9 | -29.03%-12 | -9.93%-9.3 | 2.76%-8.46 | -23.93%-8.7 | 62.38%-7.02 | -35.22%-18.66 |
| Dividend per share | ||||||||||
| Currency Unit | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD | AUD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion with Explanatory Notes | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg